Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129

被引：0
|
作者：
Gillison, M. L. [1 ]
Harris, J. [1 ]
Westra, W. [1 ]
Chung, C. [1 ]
Jordan, R. [1 ]
Rosenthal, D. [1 ]
Nguyen-Tan, P. [1 ]
Spanos, W. J. [1 ]
Redmond, K. P. [1 ]
Ang, K. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6003
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer
    Zarrabi, Kevin K.
    Galloway, Thomas J.
    Flieder, Douglas B.
    Kumar, Sameera S.
    Judd, Julia
    Bauman, Jessica R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (08): : E25 - E30
  • [42] Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients
    Scartozzi, M
    De Nictolis, M
    Galizia, E
    Carassai, P
    Bianchi, F
    Berardi, R
    Gesuita, R
    Piga, A
    Cellerino, R
    Porfiri, E
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) : 1144 - 1149
  • [43] Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer
    Heilbroner, Samuel P.
    Xanthopoulos, Eric P.
    Buono, Donna
    Huang, Yongmei
    Carrier, Daniel
    Shan, Anand
    Kim, Jerry
    Corradetti, Michael
    Wright, Jason D.
    Neugut, Alfred I.
    Hershman, Dawn L.
    Cheng, Simon K.
    LUNG CANCER, 2019, 129 : 8 - 15
  • [44] Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status
    Robinson, S. D.
    Towler, J. D.
    Kitson, R.
    Saleh, D.
    Younan, H-C.
    Mukhopadhyay, S.
    Weir, J.
    Gujral, D. M.
    CLINICAL ONCOLOGY, 2021, 33 (12)
  • [45] Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment
    Cramer, John D.
    Ferris, Robert L.
    Kim, Seungwon
    Duvvuri, Umamaheswar
    ORAL ONCOLOGY, 2018, 87 : 170 - 176
  • [46] Stage III-IV non small cell lung cancer: the impact of SUVmax and %ΔSUVmax in predicting survival after chemotherapy
    Cistaro, A.
    Quartuccio, N.
    Mojtahedi, A.
    Fania, P.
    Cucinotta, M.
    Campenni, A.
    Ficola, U.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S466 - S466
  • [47] Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes
    Khaled Al-Qahtani
    Jen Rieger
    Jeffery R. Harris
    Alex Mlynarek
    David Williams
    Tahera Islam
    Hadi Seikaly
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 2027 - 2033
  • [48] Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes
    Al-Qahtani, Khaled
    Rieger, Jen
    Harris, Jeffery R.
    Mlynarek, Alex
    Williams, David
    Islam, Tahera
    Seikaly, Hadi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (08) : 2027 - 2033
  • [49] Improved survival in patients with Stage III-IV head and neck cancer treated with radiotherapy as primary local treatment modality
    Rusthoven, Kyle E.
    Raben, David
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 343 - 350
  • [50] The prognostic role of gender, race and human papillomavirus (HPV) in oropharyngeal squamous cell cancer (OPC) and non-oropharyngeal head and neck squamous cell cancer (non-OP HNC).
    Fakhry, Carole
    Westra, William H.
    Wang, Steven
    VanZante, Annemieke
    Zhang, Yuehan
    Rettig, Eleni Marie
    Wentz, Alicia
    Kim, Young Jun
    Bishop, Justin A.
    Koch, Wayne
    Gourin, Christine Gail
    Richmon, Jeremy
    Eisele, David
    D'Souza, Gypsyamber
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345